SOC

GoGlobal Announces SOC 2 Certification for BlueOcean Platform, Strengthening Global HR Data Security and Reliability

Retrieved on: 
Wednesday, March 6, 2024

Miami, Florida--(Newsfile Corp. - March 6, 2024) - GoGlobal, a leader in international expansion and global human resources (HR) solutions, is pleased to announce its BlueOcean platform has achieved SOC 2 certification.

Key Points: 
  • Miami, Florida--(Newsfile Corp. - March 6, 2024) - GoGlobal, a leader in international expansion and global human resources (HR) solutions, is pleased to announce its BlueOcean platform has achieved SOC 2 certification.
  • Margaret Yip, Partner at GoGlobal, says, "Achieving SOC 2 certification for our BlueOcean platform, in tandem with our ISO 27001 accreditation , is a testament to our unwavering commitment to data protection.
  • The SOC 2 certification process, conducted by independent auditors from EY , affirms BlueOcean's compliance with the highest information security standards.
  • Achieving SOC 2 certification for our BlueOcean platform, in tandem with our ISO 27001 accreditation, is a testament to our unwavering commitment to data protection.

Most powerful series-production Porsche of all time sets record lap times at Laguna Seca and the Nürburgring; the Taycan Turbo GT and Taycan Turbo GT with Weissach Package

Retrieved on: 
Monday, March 11, 2024

In the Taycan Turbo GT and the Taycan Turbo GT with Weissach Package in particular, our engineers have achieved this in stunning fashion.

Key Points: 
  • In the Taycan Turbo GT and the Taycan Turbo GT with Weissach Package in particular, our engineers have achieved this in stunning fashion.
  • The Taycan Turbo GT and Taycan Turbo GT with Weissach Package are the new sporting flagship models and take Taycan performance to the next level.
  • The Taycan Turbo GT features the Sport Chrono package from the Taycan Turbo S.
    Designed for performance on the track: Taycan Turbo GT with Weissach Package
    The Taycan Turbo GT with optional Weissach Package is even more laser sharp in its positioning.
  • The Manufacturer’s Suggested Retail Price (MSRP) for the 2025 Taycan Turbo GT and the Taycan Turbo GT with Weissach Package start at $230,000.

Nightfall AI Transforms Enterprise DLP with AI-Native Platform

Retrieved on: 
Monday, March 11, 2024

SAN FRANCISCO, March 11, 2024 (GLOBE NEWSWIRE) -- Nightfall AI today unveiled new capabilities to transform data security for the modern enterprise.

Key Points: 
  • SAN FRANCISCO, March 11, 2024 (GLOBE NEWSWIRE) -- Nightfall AI today unveiled new capabilities to transform data security for the modern enterprise.
  • The industry’s first generative AI (GenAI) DLP platform now offers coverage for SaaS Security Posture Management (SSPM), data encryption, data exfiltration prevention and sensitive data protection.
  • Nightfall is the first DLP solution to leverage GenAI to prevent data leaks without disrupting modern workflows.
  • “Nightfall’s industry-first GenAI detectors make the platform a smarter, more scalable way to protect sensitive data in the enterprise.

Mobileye Global Inc. Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Mobileye Global Inc. of Deadline in Securities Fraud Class Action Lawsuit

Retrieved on: 
Monday, March 11, 2024

The action charges Mobileye with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects.

Key Points: 
  • The action charges Mobileye with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects.
  • As a result of Mobileye’s materially misleading statements and omissions to the public, Mobileye’ s investors have suffered significant losses.
  • Kessler Topaz Meltzer & Check, LLP encourages Mobileye investors who have suffered significant losses to contact the firm directly to acquire more information.
  • The class action complaint against Mobileye, Mcauliffe v. Mobileye Global Inc., et al., Case No.

MOBILEYE INVESTOR ALERT: Kirby McInerney LLP Alerts Mobileye Global Inc. (MBLY) Investors of Looming Lead Plaintiff Deadline in Class Action Lawsuit

Retrieved on: 
Friday, March 8, 2024

The lawsuit alleges that Mobileye made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects.

Key Points: 
  • The lawsuit alleges that Mobileye made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects.
  • Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation.
  • Additional information about the firm can be found at Kirby McInerney LLP’s website: https://www.kmllp.com .
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mobileye Global Inc. of Class Action Lawsuit and Upcoming Deadlines – MBLY

Retrieved on: 
Thursday, March 7, 2024

NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Mobileye Global Inc. (“Mobileye” or the “Company”) (NASDAQ: MBLY) and certain officers.

Key Points: 
  • NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Mobileye Global Inc. (“Mobileye” or the “Company”) (NASDAQ: MBLY) and certain officers.
  • If you are a shareholder who purchased or otherwise acquired Mobileye securities during the Class Period, you have until March 18, 2024 to ask the Court to appoint you as Lead Plaintiff for the class.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Mobileye

Retrieved on: 
Thursday, March 7, 2024

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia.

Key Points: 
  • Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia.
  • The firm has recovered hundreds of millions of dollars for investors since its founding in 1995.
  • Faruqi & Faruqi, LLP also encourages anyone with information regarding Mobileye’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
  • The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com ).

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Mobileye Global Inc. (MBLY)

Retrieved on: 
Wednesday, March 6, 2024

You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

Key Points: 
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
  • If you purchased or otherwise acquired Mobileye securities during the Class Period, you may move the Court no later than March 18, 2024 to request appointment as lead plaintiff in this putative class action lawsuit.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles

MSPs Have Voted and Huntress Takes Home Best Security Solution Award

Retrieved on: 
Wednesday, March 6, 2024

COLUMBIA, Md., March 06, 2024 (GLOBE NEWSWIRE) -- Huntress , the people-powered cybersecurity platform for small to mid-sized businesses (SMBs) and the managed service providers that support them, today announced it has been awarded Best Security Solution by MSPs who attended the ChannelPro event February 28-29 in Chicago.

Key Points: 
  • COLUMBIA, Md., March 06, 2024 (GLOBE NEWSWIRE) -- Huntress , the people-powered cybersecurity platform for small to mid-sized businesses (SMBs) and the managed service providers that support them, today announced it has been awarded Best Security Solution by MSPs who attended the ChannelPro event February 28-29 in Chicago.
  • The live event hosted a full house of managed service providers and notable channel experts who voted Huntress EDR and MDR for Microsoft 365 best security solutions, and Huntress’s booth presence as The Best in the Expo Hall.
  • “This award is another testament to the tremendous value that our products and our 24/7 human-led security operations (SOC) team bring to our MSP partners and their end customers," said Jordan Redd, Vice President of Channel and Customer Account Management for Huntress.

Bioxytran Announces Preprint of Shingles Case Study Showing Clearance Using a Topical Galectin-3 Antagonist

Retrieved on: 
Wednesday, March 6, 2024

BOSTON, MASSACHUSETTS, March 06, 2024 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (BIXT), (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat viral diseases, announced today the preprint in ResearchGate entitled “Association of Rapid Shingles Lesion Clearance and Regression of Herpes Zoster Neuralgia in Case Study Using Topical Galectin-3 Antagonism” showed a time lapsed clearance of the shingles lesions using a topical Galectin-3 antagonist. Vaccines have been developed to prevent shingles, but there are few effective antiviral therapies capable of treating the outbreak while reducing the pain associated with the condition. The case study demonstrated a rapid response in the reduction of pain the size of the lesion area, due to a galectin antagonist.

Key Points: 
  • BOSTON, MASSACHUSETTS, March 06, 2024 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. ( BIXT ), (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat viral diseases, announced today the preprint in ResearchGate entitled “Association of Rapid Shingles Lesion Clearance and Regression of Herpes Zoster Neuralgia in Case Study Using Topical Galectin-3 Antagonism” showed a time lapsed clearance of the shingles lesions using a topical Galectin-3 antagonist.
  • Vaccines have been developed to prevent shingles, but there are few effective antiviral therapies capable of treating the outbreak while reducing the pain associated with the condition.
  • The case study demonstrated a rapid response in the reduction of pain the size of the lesion area, due to a galectin antagonist.
  • “This case study constitutes a proof of concept of the benefit of using a galectin antagonist in human shingles infection.